Evidence map›Paper›PMID 39643767›Full record

ArticleActa neuropathologica2024

Neurodegeneration in the cortical sulcus is a feature of chronic traumatic encephalopathy and associated with repetitive head impacts.

Raymond Nicks, Arsal Shah, Spiro Anthony Stathas, Daniel Kirsch, Sarah M Horowitz, Nicole Saltiel, Samantha M Calderazzo, Morgane L M D Butler, Kerry A Cormier, Nurgul Aytan and 23 more

Abstract read
In one paragraph

Article in Acta neuropathologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Raymond Nicks *Boston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA.
Arsal Shah *Boston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA.
Spiro Anthony StathasBoston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA.
Daniel KirschBoston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA.
Sarah M HorowitzBoston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA.
Nicole SaltielBoston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA.
Samantha M CalderazzoBoston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA.
Morgane L M D ButlerBoston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA.
Kerry A CormierBoston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA.
Nurgul AytanBoston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA.
Fatima Tu-ZahraBoston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA.
Rebecca MathiasBoston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA.
Farwa FaheemBoston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA.
Suzie MarcusVA Bedford Healthcare System, Bedford, MA, USA.
Elizabeth SpurlockBoston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA.
Lucas FishbeinBoston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA.
Camille D EsnaultBoston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA.
Alexandra BodenBoston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA.
Grace RosenVA Boston Healthcare System, Boston, MA, USA.
Weiming XiaBoston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA.
Sarah DaleyBoston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA.
Gaoyuan MengVA Bedford Healthcare System, Bedford, MA, USA.
Brett R MartinBoston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA.
Daniel H DaneshvarDepartment of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, MA, USA.
Christopher J NowinskiBoston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA.
Michael L AloscoBoston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA.
Jesse MezBoston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA.
Yorghos TripodisBoston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA.
Bertrand R HuberBoston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA.
Victor E AlvarezBoston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA.
Jonathan D CherryBoston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA.
Ann C McKeeBoston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA.
Thor D SteinBoston University Alzheimer's Disease and CTE Center, Boston Chobanian & Avedisian University School of Medicine, Boston, MA, USA. tdstein@bu.edu.ORCID 0000-0001-6954-4477

Funding

TBDU19AG068753 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Lindsay A. Farrer · 2020 to 2026
$42.4M
FRAMINGHAM HEART STUDY - YEAR 5 EXAM75N92019D00031 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · 2019 to 2024
$29.8M
Neuropathology CoreP30AG013846 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KOWALL, NEIL W. · 1996 to 2020
$29.1M
RL5: Research Education CoreP30AG072978 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Ann C. McKee · 2021 to 2026
$25.6M
EPIDEMIOLOGY OF DEMENTIA IN THE FRAMINGHAM STUDYR01AG008122 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI AU, RHODA, SESHADRI, SUDHA · 1989 to 2015
$14.4M
Temporal Trends, Novel Imaging and Molecular Characterization of Preclinical and Clinical Alzheimer's Disease in the Framingham CohortsR01AG054076 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI DECARLI, CHARLES, SESHADRI, SUDHA · 2016 to 2020
$12.3M
Traumatic Brain Injury and Repetitive Head Impacts: Contributions to AD/ADRD and CTE Neuropathology and Resulting Clinical SyndromesU54NS115266 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI STEIN, THOR · 2019 to 2023
$10.3M
CTE and Posttraumatic Neurodegeneration: Neuropathology and Ex Vivo ImagingU01NS086659 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MCKEE, ANN C. · 2014 to 2017
$6.1M
Age-Associated Lipidomic Changes in Alzheimer's DiseaseRF1AG057768 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BLUSZTAJN, JAN KRZYSZTOF, STEIN, THOR · 2019 to 2021
$4.5M
Epigenetic changes in synaptic and inflammatory genes involved in the age-dependent development of Alzheimer's disease pathologies andcognitive declineRF1AG054156 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI AU, RHODA, RYU, HOON · 2016 to 2018
$3.4M
Age-Associated Lipidomic Changes in Alzheimer's DiseaseR56AG057768 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BLUSZTAJN, JAN KRZYSZTOF, STEIN, THOR · 2017 to 2017
$820k
Repetitive Head Impact Exposure and Later-Life White Matter Signal Abnormalities: An Investigation in Former NFL Players, Subjects with Alzheimer's Disease, and Cognitively Normal ControlsK23NS102399 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ALOSCO, MICHAEL · 2018 to 2022
$793k
Alzheimer's Association NIRG-305779Alzheimer's Association NIRG-362697BLRD VA I01 BX005161CSRD VA I01 CX001038National Institute of Aging AG08122National Institute of Aging Boston University AD Center P30AG13846NHLBI NIH HHS 75N92019D00031NHLBI NIH HHS HHSN268201000011CNHLBI NIH HHS HHSN2682015000011NHLBI NIH HHS HHSN268201500001CNHLBI NIH HHS HHSN268201500001INHLBI NIH HHS HHSN268201500011CNIA NIH HHS AG054076NIA NIH HHS K23 AG046377NIA NIH HHS K23AG046377NIA NIH HHS P30 AG013846NIA NIH HHS P30 AG072978NIA NIH HHS R01 AG008122NIA NIH HHS R01 AG054076NIA NIH HHS R56 AG057768NIA NIH HHS R56AG057768NIA NIH HHS RF1 AG054156NIA NIH HHS RF1AG054156NIA NIH HHS RF1 AG057768NIA NIH HHS RF1AG057768NIA NIH HHS U19 AG068753NIA NIH HHS U19AG068753NINDS NIH HHS F31 NS127449NINDS NIH HHS F31NS127449NINDS NIH HHS K23 NS102399NINDS NIH HHS K23NS102399NINDS NIH HHS U01 NS086659NINDS NIH HHS U01NS086659NINDS NIH HHS U54 NS115266NINDS NIH HHS U54NS115266Peer Reviewed Alzheimer's Research Program PRARP #13267017U.S. Department of Veterans Affairs I01BX005161U.S. Department of Veterans Affairs I01BX005933
6 · The paper itself

Abstract

Neurodegeneration is a seminal feature of many neurological disorders. Chronic traumatic encephalopathy (CTE) is caused by repetitive head impacts (RHI) and is characterized by sulcal tau pathology. However, quantitative assessments of regional neurodegeneration in CTE have not been described. In this study, we quantified three key neurodegenerative measures, including cortical thickness, neuronal density, and synaptic proteins, in contact sport athletes (n = 185) and non-athlete controls (n = 52) within the sulcal depth, middle, and gyral crest of the dorsolateral frontal cortex. Cortical thickness and neuronal density were decreased within the sulcus in CTE compared to controls (p's < 0.05). Measurements of synaptic proteins within the gyral crest showed a reduction of α-synuclein with CTE stage (p = 0.002) and variable changes in PSD-95 density. After adjusting for age, multiple linear regression models demonstrated a strong association between the duration of contact sports play and cortical thinning (p = 0.001) and neuronal loss (p = 0.032) within the sulcus. Additional regression models, adjusted for tau pathology, suggest that within the sulcus, the duration of play was associated with neuronal loss predominantly through tau pathology. In contrast, the association of duration of play with cortical thinning was minimally impacted by tau pathology. Overall, CTE is associated with cortical atrophy and a predominant sulcal neurodegeneration. Furthermore, the duration of contact sports play is associated with measures of neurodegeneration that are more severe in the cortical sulcus and may occur through tau-dependent and independent mechanisms.

Indexed as

Cerebral CortexChronic Traumatic EncephalopathyAdultAgedalpha-SynucleinAthletesAthletic InjuriesFemaleHumansMaleMiddle AgedNerve DegenerationNeurodegenerative DiseasesNeuronstau ProteinsYoung Adultalpha-Synucleintau ProteinsChronic traumatic encephalopathyContact sportsCortical sulcusCortical thinningNeurodegenerationNeuronal lossRepetitive head impactsSynaptic lossTau pathology

Identifiers

PMID39643767
PMCPMC11624223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.